1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Market Introduction
2. Executive Summary
2.1. Market Snapshot: Global Cirrhosis Market
2.1.1. Global Cirrhosis Market, By Etiology
2.1.2. Global Cirrhosis Market, By Compensated vs. Decompensated Cirrhosis
2.1.3. Global Cirrhosis Market, By Clinical Presentation
2.1.4. Global Cirrhosis Market, By Disease Severity
2.1.5. Global Cirrhosis Market, By Distribution Channels
2.1.6. Global Cirrhosis Market, By Treatment Approaches
2.1.7. Global Cirrhosis Market, By Region
2.2. Insights from Primary Respondents
3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Cirrhosis Market Value, 2017-2030, (US$ Mn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Cirrhosis Market Drivers
3.2.2. Cirrhosis Market Restraints
3.2.3. Cirrhosis Market Opportunities
3.2.4. Major Cirrhosis Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Etiology
3.5.2. Compensated vs. Decompensated Cirrhosis
3.5.3. Clinical Presentation
3.5.4. Disease Severity
3.5.5. Distribution Channels
3.5.6. Treatment Approaches
3.5.7. Geography
4. Market Competitive Landscape Analysis
4.1. Company Market Share Analysis, 2022
4.1.1. Global Cirrhosis Market: Company Market Share, Value 2022
4.1.2. Global Cirrhosis Market: Top 6 Company Market Share, Value 2022
4.1.3. Global Cirrhosis Market: Top 3 Company Market Share, Value 2022
4.2. Global Cirrhosis Market: Company Revenue Share Analysis, 2022
4.3. Company Assessment Metrics, 2022
4.3.1. Stars
4.3.2. Emerging Leaders
4.3.3. Pervasive Players
4.3.4. Participants
4.4. Startups/ SMEs Assessment Metrics, 2022
4.4.1. Progressive Companies
4.4.2. Responsive Companies
4.4.3. Dynamic Companies
4.4.4. Starting Blocks
4.5. Strategic Development
4.5.1. Acquisition and Mergers
4.5.2. New Product Launch
4.5.3. Regional Expansion
4.5.4. Partnerships
4.6. Key Player Product Matrix
4.7. Potential for New Players in the Global Cirrhosis Market
5. Premium Insights
5.1. STAR (Situation, Task, Action, Results) Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Bargaining Power of Buyers/Consumers
5.2.3. Bargaining Power of Suppliers
5.2.4. Threat of Substitute Types
5.2.5. Intensity of Competitive Rivalry
5.3. PESTEL Analysis
5.3.1. Political Factors
5.3.2. Economic Factors
5.3.3. Social Factors
5.3.4. Technological Factors
5.3.5. Environmental Factors
5.3.6. Legal Factors
5.4. Key Market Trends
5.4.1. Demand Side Trends
5.4.2. Supply Side Trends
5.5. Value Chain Analysis
5.6. Technology Analysis
5.6.1. Research and development in the global market
5.6.2. Patent Analysis
5.6.3. Emerging technologies and their potential disruption to the market
5.7. Consumer Behaviour Analysis
5.7.1. Consumer Preferences and Expectations
5.7.2. Factors Influencing Consumer Buying Decisions
5.7.2.1. North America
5.7.2.2. Europe
5.7.2.3. Asia Pacific
5.7.2.4. Latin America
5.7.2.5. Middle East and Africa
5.7.3. Consumer Pain Points
5.8. Analysis and Recommendations
5.9. Adjacent Market Analysis
6. Market Positioning of Key Players, 2022
6.1. Company market share of key players, 2022
6.2. Competitive Benchmarking
6.3. Market Positioning of Key Vendors
6.4. Geographical Presence Analysis
6.5. Major Strategies Adopted by Key Players
6.5.1. Key Strategies Analysis
6.5.2. Mergers and Acquisitions
6.5.3. Partnerships
6.5.4. Product Launch
6.5.5. Geographical Expansion
6.5.6. Others
7. Impact Analysis of COVID-19 and Russia – Ukraine War on Cirrhosis Market
7.1. Ukraine-Russia War Impact
7.1.1. Uncertainty and Economic Instability
7.1.2. Supply chain disruptions
7.1.3. Regional market shifts
7.1.4. Shift in government priorities
7.2. COVID-19 Impact Analysis
7.2.1. Supply Chain Disruptions
7.2.2. Demand Fluctuations
7.2.3. Shift in Product Mix
7.2.4. Reduced Industrial Activity
7.2.5. Regional Impact Analysis
7.2.5.1. North America
7.2.5.2. Europe
7.2.5.3. Asia Pacific
7.2.5.4. Latin America
7.2.5.5. Middle East and Africa
8. Global Cirrhosis Market, By Etiology
8.1. Global Cirrhosis Market Overview, by Etiology
8.1.1. Global Cirrhosis Market Revenue Share, By Etiology, 2022 Vs 2030 (in %)
8.2. Alcoholic Cirrhosis
8.2.1. Global Cirrhosis Market, By Alcoholic Cirrhosis, By Region, 2017-2030 (US$ Mn)
8.2.2. Market Dynamics for Alcoholic Cirrhosis
8.2.2.1. Drivers
8.2.2.2. Restraints
8.2.2.3. Opportunities
8.2.2.4. Trends
8.3. Non-Alcoholic Fatty Liver Disease (NAFLD) Cirrhosis
8.3.1. Global Cirrhosis Market, By Non-Alcoholic Fatty Liver Disease (NAFLD) Cirrhosis, By Region, 2017-2030 (US$ Mn)
8.3.2. Market Dynamics for Non-Alcoholic Fatty Liver Disease (NAFLD) Cirrhosis
8.3.2.1. Drivers
8.3.2.2. Restraints
8.3.2.3. Opportunities
8.3.2.4. Trends
8.4. Viral Hepatitis-Related Cirrhosis (Hepatitis B, Hepatitis C)
8.4.1. Global Cirrhosis Market, By Viral Hepatitis-Related Cirrhosis (Hepatitis B, Hepatitis C), By Region, 2017-2030 (US$ Mn)
8.4.2. Market Dynamics for Viral Hepatitis-Related Cirrhosis (Hepatitis B, Hepatitis C)
8.4.2.1. Drivers
8.4.2.2. Restraints
8.4.2.3. Opportunities
8.4.2.4. Trends
8.5. Autoimmune Cirrhosis
8.5.1. Global Cirrhosis Market, By Autoimmune Cirrhosis, By Region, 2017-2030 (US$ Mn)
8.5.2. Market Dynamics for Autoimmune Cirrhosis
8.5.2.1. Drivers
8.5.2.2. Restraints
8.5.2.3. Opportunities
8.5.2.4. Trends
8.6. Genetic and Metabolic Disorders-Related Cirrhosis
8.6.1. Global Cirrhosis Market, By Genetic and Metabolic Disorders-Related Cirrhosis, By Region, 2017-2030 (US$ Mn)
8.6.2. Market Dynamics for Genetic and Metabolic Disorders-Related Cirrhosis
8.6.2.1. Drivers
8.6.2.2. Restraints
8.6.2.3. Opportunities
8.6.2.4. Trends
9. Global Cirrhosis Market, By Compensated vs. Decompensated Cirrhosis
9.1. Global Cirrhosis Market Overview, by Compensated vs. Decompensated Cirrhosis
9.1.1. Global Cirrhosis Market Revenue Share, By Compensated vs. Decompensated Cirrhosis, 2022 Vs 2030 (in %)
9.2. Compensated Cirrhosis
9.2.1. Global Cirrhosis Market, By Compensated Cirrhosis, By Region, 2017-2030 (US$ Mn)
9.2.2. Market Dynamics for Compensated Cirrhosis
9.2.2.1. Drivers
9.2.2.2. Restraints
9.2.2.3. Opportunities
9.2.2.4. Trends
9.3. Decompensated Cirrhosis
9.3.1. Global Cirrhosis Market, By Decompensated Cirrhosis, By Region, 2017-2030 (US$ Mn)
9.3.2. Market Dynamics for Decompensated Cirrhosis
9.3.2.1. Drivers
9.3.2.2. Restraints
9.3.2.3. Opportunities
9.3.2.4. Trends
10. Global Cirrhosis Market, By Clinical Presentation
10.1. Global Cirrhosis Market Overview, by Clinical Presentation
10.1.1. Global Cirrhosis Market Revenue Share, By Clinical Presentation, 2022 Vs 2030 (in %)
10.2. Asymptomatic Cirrhosis
10.2.1. Global Cirrhosis Market, By Asymptomatic Cirrhosis, By Region, 2017-2030 (US$ Mn)
10.2.2. Market Dynamics for Asymptomatic Cirrhosis
10.2.2.1. Drivers
10.2.2.2. Restraints
10.2.2.3. Opportunities
10.2.2.4. Trends
10.3. Symptoms of Decompensated Cirrhosis (Ascites, Variceal Bleeding, Hepatic Encephalopathy, Jaundice)
10.3.1. Global Cirrhosis Market, By Symptoms of Decompensated Cirrhosis (Ascites, Variceal Bleeding, Hepatic Encephalopathy, Jaundice), By Region, 2017-2030 (US$ Mn)
10.3.2. Market Dynamics for Symptoms of Decompensated Cirrhosis (Ascites, Variceal Bleeding, Hepatic Encephalopathy, Jaundice)
10.3.2.1. Drivers
10.3.2.2. Restraints
10.3.2.3. Opportunities
10.3.2.4. Trends
11. Global Cirrhosis Market, By Disease Severity
11.1. Global Cirrhosis Market Overview, by Disease Severity
11.1.1. Global Cirrhosis Market Revenue Share, By Disease Severity, 2022 Vs 2030 (in %)
11.2. Child-Pugh Score Class A
11.2.1. Global Cirrhosis Market, By Child-Pugh Score Class A, By Region, 2017-2030 (US$ Mn)
11.2.2. Market Dynamics for Child-Pugh Score Class A
11.2.2.1. Drivers
11.2.2.2. Restraints
11.2.2.3. Opportunities
11.2.2.4. Trends
11.3. Child-Pugh Score Class B
11.3.1. Global Cirrhosis Market, By Child-Pugh Score Class B, By Region, 2017-2030 (US$ Mn)
11.3.2. Market Dynamics for Child-Pugh Score Class B
11.3.2.1. Drivers
11.3.2.2. Restraints
11.3.2.3. Opportunities
11.3.2.4. Trends
11.4. Child-Pugh Score Class C
11.4.1. Global Cirrhosis Market, By Child-Pugh Score Class C, By Region, 2017-2030 (US$ Mn)
11.4.2. Market Dynamics for Child-Pugh Score Class C
11.4.2.1. Drivers
11.4.2.2. Restraints
11.4.2.3. Opportunities
11.4.2.4. Trends
12. Global Cirrhosis Market, By Distribution Channels
12.1. Global Cirrhosis Market Overview, by Distribution Channels
12.1.1. Global Cirrhosis Market Revenue Share, By Distribution Channels, 2022 Vs 2030 (in %)
12.2. Hospitals and Clinics
12.2.1. Global Cirrhosis Market, By Hospitals and Clinics, By Region, 2017-2030 (US$ Mn)
12.2.2. Market Dynamics for Hospitals and Clinics
12.2.2.1. Drivers
12.2.2.2. Restraints
12.2.2.3. Opportunities
12.2.2.4. Trends
12.3. Specialty Pharmacies
12.3.1. Global Cirrhosis Market, By Specialty Pharmacies, By Region, 2017-2030 (US$ Mn)
12.3.2. Market Dynamics for Specialty Pharmacies
12.3.2.1. Drivers
12.3.2.2. Restraints
12.3.2.3. Opportunities
12.3.2.4. Trends
12.4. Retail Pharmacies
12.4.1. Global Cirrhosis Market, By Retail Pharmacies, By Region, 2017-2030 (US$ Mn)
12.4.2. Market Dynamics for Retail Pharmacies
12.4.2.1. Drivers
12.4.2.2. Restraints
12.4.2.3. Opportunities
12.4.2.4. Trends
13. Global Cirrhosis Market, By Treatment Approaches
13.1. Global Cirrhosis Market Overview, by Treatment Approaches
13.1.1. Global Cirrhosis Market Revenue Share, By Treatment Approaches, 2022 Vs 2030 (in %)
13.2. Medications (Antivirals, Immunosuppressants)
13.2.1. Global Cirrhosis Market, By Medications (Antivirals, Immunosuppressants), By Region, 2017-2030 (US$ Mn)
13.2.2. Market Dynamics for Medications (Antivirals, Immunosuppressants)
13.2.2.1. Drivers
13.2.2.2. Restraints
13.2.2.3. Opportunities
13.2.2.4. Trends
13.3. Lifestyle Modifications (Diet, Alcohol Abstinence)
13.3.1. Global Cirrhosis Market, By Lifestyle Modifications (Diet, Alcohol Abstinence), By Region, 2017-2030 (US$ Mn)
13.3.2. Market Dynamics for Lifestyle Modifications (Diet, Alcohol Abstinence)
13.3.2.1. Drivers
13.3.2.2. Restraints
13.3.2.3. Opportunities
13.3.2.4. Trends
13.4. Surgical Interventions (Liver Transplantation)
13.4.1. Global Cirrhosis Market, By Surgical Interventions (Liver Transplantation), By Region, 2017-2030 (US$ Mn)
13.4.2. Market Dynamics for Surgical Interventions (Liver Transplantation)
13.4.2.1. Drivers
13.4.2.2. Restraints
13.4.2.3. Opportunities
13.4.2.4. Trends
14. Global Cirrhosis Market, By Region
14.1. Global Cirrhosis Market Overview, by Region
14.1.1. Global Cirrhosis Market, By Region, 2022 vs 2030 (in%)
14.2. Etiology
14.2.1. Global Cirrhosis Market, By Etiology, 2017-2030 (US$ Mn)
14.3. Compensated vs. Decompensated Cirrhosis
14.3.1. Global Cirrhosis Market, By Compensated vs. Decompensated Cirrhosis, 2017-2030 (US$ Mn)
14.4. Clinical Presentation
14.4.1. Global Cirrhosis Market, By Clinical Presentation, 2017-2030 (US$ Mn)
14.5. Disease Severity
14.5.1. Global Cirrhosis Market, By Disease Severity, 2017-2030 (US$ Mn)
14.6. Distribution Channels
14.6.1. Global Cirrhosis Market, By Distribution Channels, 2017-2030 (US$ Mn)
14.7. Treatment Approaches
14.7.1. Global Cirrhosis Market, By Treatment Approaches, 2017-2030 (US$ Mn)
15. North America Cirrhosis Market Analysis
15.1. Overview
15.1.1. Market Dynamics for North America
15.1.1.1. Drivers
15.1.1.2. Restraints
15.1.1.3. Opportunities
15.1.1.4. Trends
15.2. North America Cirrhosis Market, by Etiology, 2017-2030(US$ Mn)
15.2.1. Overview
15.2.2. SRC Analysis
15.3. North America Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2017-2030(US$ Mn)
15.3.1. Overview
15.3.2. SRC Analysis
15.4. North America Cirrhosis Market, by Clinical Presentation, 2017-2030(US$ Mn)
15.4.1. Overview
15.4.2. SRC Analysis
15.5. North America Cirrhosis Market, by Disease Severity, 2017-2030(US$ Mn)
15.5.1. Overview
15.5.2. SRC Analysis
15.6. North America Cirrhosis Market, by Distribution Channels, 2017-2030(US$ Mn)
15.6.1. Overview
15.6.2. SRC Analysis
15.7. North America Cirrhosis Market, by Treatment Approaches, 2017-2030(US$ Mn)
15.7.1. Overview
15.7.2. SRC Analysis
15.8. North America Cirrhosis Market, by Country, 2017-2030 (US$ Mn)
15.8.1. North America Cirrhosis Market, by Country, 2022 Vs 2030 (in%)
15.8.2. U.S.
15.8.3. Canada
15.8.4. Mexico
16. Europe Cirrhosis Market Analysis
16.1. Overview
16.1.1. Market Dynamics for North America
16.1.1.1. Drivers
16.1.1.2. Restraints
16.1.1.3. Opportunities
16.1.1.4. Trends
16.2. Europe Cirrhosis Market, by Etiology, 2017-2030(US$ Mn)
16.2.1. Overview
16.2.2. SRC Analysis
16.3. Europe Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2017-2030(US$ Mn)
16.3.1. Overview
16.3.2. SRC Analysis
16.4. Europe Cirrhosis Market, by Clinical Presentation, 2017-2030(US$ Mn)
16.4.1. Overview
16.4.2. SRC Analysis
16.5. Europe Cirrhosis Market, by Disease Severity, 2017-2030(US$ Mn)
16.5.1. Overview
16.5.2. SRC Analysis
16.6. Europe Cirrhosis Market, by Distribution Channels, 2017-2030(US$ Mn)
16.6.1. Overview
16.6.2. SRC Analysis
16.7. Europe Cirrhosis Market, by Treatment Approaches, 2017-2030(US$ Mn)
16.7.1. Overview
16.7.2. SRC Analysis
16.8. Europe Cirrhosis Market, by Country, 2017-2030 (US$ Mn)
16.8.1. Europe Cirrhosis Market, by Country, 2022 Vs 2030 (in%)
16.8.2. UK
16.8.3. France
16.8.4. Germany
16.8.5. Italy
16.8.6. Spain
16.8.7. Benelux
16.8.8. Russia
16.8.9. Rest of Europe
17. Asia Pacific Cirrhosis Market Analysis
17.1. Overview
17.1.1. Market Dynamics for North America
17.1.1.1. Drivers
17.1.1.2. Restraints
17.1.1.3. Opportunities
17.1.1.4. Trends
17.2. Asia Pacific Cirrhosis Market, by Etiology, 2017-2030(US$ Mn)
17.2.1. Overview
17.2.2. SRC Analysis
17.3. Asia Pacific Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2017-2030(US$ Mn)
17.3.1. Overview
17.3.2. SRC Analysis
17.4. Asia Pacific Cirrhosis Market, by Clinical Presentation, 2017-2030(US$ Mn)
17.4.1. Overview
17.4.2. SRC Analysis
17.5. Asia Pacific Cirrhosis Market, by Disease Severity, 2017-2030(US$ Mn)
17.5.1. Overview
17.5.2. SRC Analysis
17.6. Asia Pacific Cirrhosis Market, by Distribution Channels, 2017-2030(US$ Mn)
17.6.1. Overview
17.6.2. SRC Analysis
17.7. Asia Pacific Cirrhosis Market, by Treatment Approaches, 2017-2030(US$ Mn)
17.7.1. Overview
17.7.2. SRC Analysis
17.8. Asia Pacific Cirrhosis Market, by Country, 2017-2030 (US$ Mn)
17.8.1. Asia Pacific Cirrhosis Market, by Country, 2022 Vs 2030 (in%)
17.8.2. China
17.8.3. Japan
17.8.4. India
17.8.5. South Korea
17.8.6. South East Asia
17.8.7. Rest of Asia Pacific
18. Latin America Cirrhosis Market Analysis
18.1. Overview
18.1.1. Market Dynamics for North America
18.1.1.1. Drivers
18.1.1.2. Restraints
18.1.1.3. Opportunities
18.1.1.4. Trends
18.2. Latin America Cirrhosis Market, by Etiology, 2017-2030(US$ Mn)
18.2.1. Overview
18.2.2. SRC Analysis
18.3. Latin America Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2017-2030(US$ Mn)
18.3.1. Overview
18.3.2. SRC Analysis
18.4. Latin America Cirrhosis Market, by Clinical Presentation, 2017-2030(US$ Mn)
18.4.1. Overview
18.4.2. SRC Analysis
18.5. Latin America Cirrhosis Market, by Disease Severity, 2017-2030(US$ Mn)
18.5.1. Overview
18.5.2. SRC Analysis
18.6. Latin America Cirrhosis Market, by Distribution Channels, 2017-2030(US$ Mn)
18.6.1. Overview
18.6.2. SRC Analysis
18.7. Latin America Cirrhosis Market, by Treatment Approaches, 2017-2030(US$ Mn)
18.7.1. Overview
18.7.2. SRC Analysis
18.8. Latin America Cirrhosis Market, by Country, 2017-2030 (US$ Mn)
18.8.1. Latin America Cirrhosis Market, by Country, 2022 Vs 2030 (in%)
18.8.2. Brazil
18.8.3. Argentina
18.8.4. Rest of Latin America
19. Middle East Cirrhosis Market Analysis
19.1. Overview
19.1.1. Market Dynamics for North America
19.1.1.1. Drivers
19.1.1.2. Restraints
19.1.1.3. Opportunities
19.1.1.4. Trends
19.2. Middle East Cirrhosis Market, by Etiology, 2017-2030(US$ Mn)
19.2.1. Overview
19.2.2. SRC Analysis
19.3. Middle East Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2017-2030(US$ Mn)
19.3.1. Overview
19.3.2. SRC Analysis
19.4. Middle East Cirrhosis Market, by Clinical Presentation, 2017-2030(US$ Mn)
19.4.1. Overview
19.4.2. SRC Analysis
19.5. Middle East Cirrhosis Market, by Disease Severity, 2017-2030(US$ Mn)
19.5.1. Overview
19.5.2. SRC Analysis
19.6. Middle East Cirrhosis Market, by Distribution Channels, 2017-2030(US$ Mn)
19.6.1. Overview
19.6.2. SRC Analysis
19.7. Middle East Cirrhosis Market, by Treatment Approaches, 2017-2030(US$ Mn)
19.7.1. Overview
19.7.2. SRC Analysis
19.8. Middle East Cirrhosis Market, by Country, 2017-2030 (US$ Mn)
19.8.1. Middle East Cirrhosis Market, by Country, 2022 Vs 2030 (in%)
19.8.2. UAE
19.8.3. Saudi Arabia
19.8.4. Rest of Middle East
20. Africa Cirrhosis Market Analysis
20.1. Overview
20.1.1. Market Dynamics for North America
20.1.1.1. Drivers
20.1.1.2. Restraints
20.1.1.3. Opportunities
20.1.1.4. Trends
20.2. Africa Cirrhosis Market, by Etiology, 2017-2030(US$ Mn)
20.2.1. Overview
20.2.2. SRC Analysis
20.3. Africa Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2017-2030(US$ Mn)
20.3.1. Overview
20.3.2. SRC Analysis
20.4. Africa Cirrhosis Market, by Clinical Presentation, 2017-2030(US$ Mn)
20.4.1. Overview
20.4.2. SRC Analysis
20.5. Africa Cirrhosis Market, by Disease Severity, 2017-2030(US$ Mn)
20.5.1. Overview
20.5.2. SRC Analysis
20.6. Africa Cirrhosis Market, by Distribution Channels, 2017-2030(US$ Mn)
20.6.1. Overview
20.6.2. SRC Analysis
20.7. Africa Cirrhosis Market, by Treatment Approaches, 2017-2030(US$ Mn)
20.7.1. Overview
20.7.2. SRC Analysis
20.8. Africa Cirrhosis Market, by Country, 2017-2030 (US$ Mn)
20.8.1. Middle East Cirrhosis Market, by Country, 2022 Vs 2030 (in%)
20.8.2. South Africa
20.8.3. Egypt
20.8.4. Rest of Africa
21. Company Profiles
21.1. B. Braun Medical Inc
21.1.1. Company Overview
21.1.2. Products/Services Portfolio
21.1.3. Geographical Presence
21.1.4. SWOT Analysis
21.1.5. Financial Summary
21.1.5.1. Market Revenue and Net Profit (2019-2022)
21.1.5.2. Business Segment Revenue Analysis
21.1.5.3. Geographical Revenue Analysis
21.2. AstraZeneca
21.3. Histogen Inc
21.4. Stempeutics Research Pvt Ltd
21.5. Epic Research & Diagnostics Inc
21.6. Bayer AG
21.7. Sequana Medical AG
21.8. Pfizer Inc
21.9. Merck & Co. Inc
21.10. Novartis AG
21.11. Others
22. Research Methodology
22.1. Research Methodology
22.2. Phase I – Secondary Research
22.3. Phase II – Data Modelling
22.3.1. Company Share Analysis Model
22.3.2. Revenue Based Modelling
22.4. Phase III – Primary Research
22.5. Research Limitations
22.5.1. Assumptions
List of Figures
FIG. 1 Global Cirrhosis Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom Up Approach
FIG. 3 Global Cirrhosis Market Segmentation
FIG. 4 Global Cirrhosis Market, by Etiology, 2022 (US$ Mn)
FIG. 5 Global Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2022 (US$ Mn)
FIG. 6 Global Cirrhosis Market, by Clinical Presentation, 2022 (US$ Mn)
FIG. 7 Global Cirrhosis Market, by Disease Severity, 2022 (US$ Mn)
FIG. 8 Global Cirrhosis Market, by Distribution Channels, 2022 (US$ Mn)
FIG. 9 Global Cirrhosis Market, by Treatment Approaches, 2022 (US$ Mn)
FIG. 10 Global Cirrhosis Market, by Geography, 2022 (US$ Mn)
FIG. 11 Attractive Investment Proposition, by Etiology, 2022
FIG. 12 Attractive Investment Proposition, by Compensated vs. Decompensated Cirrhosis, 2022
FIG. 13 Attractive Investment Proposition, by Clinical Presentation, 2022
FIG. 14 Attractive Investment Proposition, by Disease Severity, 2022
FIG. 15 Attractive Investment Proposition, by Distribution Channels, 2022
FIG. 16 Attractive Investment Proposition, by Treatment Approaches, 2022
FIG. 17 Attractive Investment Proposition, by Geography, 2022
FIG. 18 Global Market Share Analysis of Key Cirrhosis Market Manufacturers, 2022
FIG. 19 Global Market Positioning of Key Cirrhosis Market Manufacturers, 2022
FIG. 20 Global Cirrhosis Market Value Contribution, By Etiology, 2022 & 2030 (Value %)
FIG. 21 Global Cirrhosis Market, by Alcoholic Cirrhosis, Value, 2017-2030 (US$ Mn)
FIG. 22 Global Cirrhosis Market, by Non-Alcoholic Fatty Liver Disease (NAFLD) Cirrhosis, Value, 2017-2030 (US$ Mn)
FIG. 23 Global Cirrhosis Market, by Viral Hepatitis-Related Cirrhosis (Hepatitis B, Hepatitis C), Value, 2017-2030 (US$ Mn)
FIG. 24 Global Cirrhosis Market, by Autoimmune Cirrhosis, Value, 2017-2030 (US$ Mn)
FIG. 25 Global Cirrhosis Market, by Genetic and Metabolic Disorders-Related Cirrhosis, Value, 2017-2030 (US$ Mn)
FIG. 26 Global Cirrhosis Market Value Contribution, By Compensated vs. Decompensated Cirrhosis, 2022 & 2030 (Value %)
FIG. 27 Global Cirrhosis Market, by Compensated Cirrhosis, Value, 2017-2030 (US$ Mn)
FIG. 28 Global Cirrhosis Market, by Decompensated Cirrhosis, Value, 2017-2030 (US$ Mn)
FIG. 29 Global Cirrhosis Market Value Contribution, By Clinical Presentation, 2022 & 2030 (Value %)
FIG. 30 Global Cirrhosis Market, by Asymptomatic Cirrhosis, Value, 2017-2030 (US$ Mn)
FIG. 31 Global Cirrhosis Market, by Symptoms of Decompensated Cirrhosis (Ascites, Variceal Bleeding, Hepatic Encephalopathy, Jaundice), Value, 2017-2030 (US$ Mn)
FIG. 32 Global Cirrhosis Market Value Contribution, By Disease Severity, 2022 & 2030 (Value %)
FIG. 33 Global Cirrhosis Market, by Child-Pugh Score Class A, Value, 2017-2030 (US$ Mn)
FIG. 34 Global Cirrhosis Market, by Child-Pugh Score Class B, Value, 2017-2030 (US$ Mn)
FIG. 35 Global Cirrhosis Market, by Child-Pugh Score Class C, Value, 2017-2030 (US$ Mn)
FIG. 36 Global Cirrhosis Market Value Contribution, By Distribution Channels, 2022 & 2030 (Value %)
FIG. 37 Global Cirrhosis Market, by Hospitals and Clinics, Value, 2017-2030 (US$ Mn)
FIG. 38 Global Cirrhosis Market, by Specialty Pharmacies, Value, 2017-2030 (US$ Mn)
FIG. 39 Global Cirrhosis Market, by Retail Pharmacies, Value, 2017-2030 (US$ Mn)
FIG. 40 Global Cirrhosis Market Value Contribution, By Treatment Approaches, 2022 & 2030 (Value %)
FIG. 41 Global Cirrhosis Market, by Medications (Antivirals, Immunosuppressants), Value, 2017-2030 (US$ Mn)
FIG. 42 Global Cirrhosis Market, by Lifestyle Modifications (Diet, Alcohol Abstinence), Value, 2017-2030 (US$ Mn)
FIG. 43 Global Cirrhosis Market, by Surgical Interventions (Liver Transplantation), Value, 2017-2030 (US$ Mn)
FIG. 44 North America Cirrhosis Market, 2017-2030 (US$ Mn)
FIG. 45 U.S. Cirrhosis Market, 2017-2030 (US$ Mn)
FIG. 46 Canada Cirrhosis Market, 2017-2030 (US$ Mn)
FIG. 47 Mexico Cirrhosis Market, 2017-2030 (US$ Mn)
FIG. 48 Europe Cirrhosis Market, 2017-2030 (US$ Mn)
FIG. 49 Germany Cirrhosis Market, 2017-2030 (US$ Mn)
FIG. 50 France Cirrhosis Market, 2017-2030 (US$ Mn)
FIG. 51 U.K. Cirrhosis Market, 2017-2030 (US$ Mn)
FIG. 52 Italy Cirrhosis Market, 2017-2030 (US$ Mn)
FIG. 53 Spain Cirrhosis Market, 2017-2030 (US$ Mn)
FIG. 54 Benelux Cirrhosis Market, 2017-2030 (US$ Mn)
FIG. 55 Russia Cirrhosis Market, 2017-2030 (US$ Mn)
FIG. 56 Rest of Europe Cirrhosis Market, 2017-2030 (US$ Mn)
FIG. 57 Asia Pacific Cirrhosis Market, 2017-2030 (US$ Mn)
FIG. 58 China Cirrhosis Market, 2017-2030 (US$ Mn)
FIG. 59 Japan Cirrhosis Market, 2017-2030 (US$ Mn)
FIG. 60 India Cirrhosis Market, 2017-2030 (US$ Mn)
FIG. 61 South Korea Cirrhosis Market, 2017-2030 (US$ Mn)
FIG. 62 South-East Asia Cirrhosis Market, 2017-2030 (US$ Mn)
FIG. 63 Rest of Asia Pacific Cirrhosis Market, 2017-2030 (US$ Mn)
FIG. 64 Latin America Cirrhosis Market, 2017-2030 (US$ Mn)
FIG. 65 Brazil Cirrhosis Market, 2017-2030 (US$ Mn)
FIG. 66 Argentina Cirrhosis Market, 2017-2030 (US$ Mn)
FIG. 67 Rest of Latin America Cirrhosis Market, 2017-2030 (US$ Mn)
FIG. 68 Middle East Cirrhosis Market, 2017-2030 (US$ Mn)
FIG. 69 UAE Cirrhosis Market, 2017-2030 (US$ Mn)
FIG. 70 Saudi Arabia Cirrhosis Market, 2017-2030 (US$ Mn)
FIG. 71 Rest of Middle East Cirrhosis Market, 2017-2030 (US$ Mn)
FIG. 72 Africa Cirrhosis Market, 2017-2030 (US$ Mn)
FIG. 73 South Africa Cirrhosis Market, 2017-2030 (US$ Mn)
FIG. 74 Egypt Cirrhosis Market, 2017-2030 (US$ Mn)
FIG. 75 Rest of Africa Cirrhosis Market, 2017-2030 (US$ Mn)
List of Tables
TABLE 1 Market Snapshot: Global Cirrhosis Market
TABLE 2 Global Cirrhosis Market: Market Drivers Impact Analysis
TABLE 3 Global Cirrhosis Market: Market Restraints Impact Analysis
TABLE 4 Global Cirrhosis Market, by Competitive Benchmarking, 2022
TABLE 5 Global Cirrhosis Market, by Geographical Presence Analysis, 2022
TABLE 6 Global Cirrhosis Market, by Key Strategies Analysis, 2022
TABLE 7 Global Cirrhosis Market, by Alcoholic Cirrhosis, By Region, 2017-2022 (US$ Mn)
TABLE 8 Global Cirrhosis Market, by Alcoholic Cirrhosis, By Region, 2023-2030 (US$ Mn)
TABLE 9 Global Cirrhosis Market, by Non-Alcoholic Fatty Liver Disease (NAFLD) Cirrhosis, By Region, 2017-2022 (US$ Mn)
TABLE 10 Global Cirrhosis Market, by Non-Alcoholic Fatty Liver Disease (NAFLD) Cirrhosis, By Region, 2023-2030 (US$ Mn)
TABLE 11 Global Cirrhosis Market, by Viral Hepatitis-Related Cirrhosis (Hepatitis B, Hepatitis C), By Region, 2017-2022 (US$ Mn)
TABLE 12 Global Cirrhosis Market, by Viral Hepatitis-Related Cirrhosis (Hepatitis B, Hepatitis C), By Region, 2023-2030 (US$ Mn)
TABLE 13 Global Cirrhosis Market, by Autoimmune Cirrhosis, By Region, 2017-2022 (US$ Mn)
TABLE 14 Global Cirrhosis Market, by Autoimmune Cirrhosis, By Region, 2023-2030 (US$ Mn)
TABLE 15 Global Cirrhosis Market, by Genetic and Metabolic Disorders-Related Cirrhosis, By Region, 2017-2022 (US$ Mn)
TABLE 16 Global Cirrhosis Market, by Genetic and Metabolic Disorders-Related Cirrhosis, By Region, 2023-2030 (US$ Mn)
TABLE 17 Global Cirrhosis Market, by Compensated Cirrhosis, By Region, 2017-2022 (US$ Mn)
TABLE 18 Global Cirrhosis Market, by Compensated Cirrhosis, By Region, 2023-2030 (US$ Mn)
TABLE 19 Global Cirrhosis Market, by Decompensated Cirrhosis, By Region, 2017-2022 (US$ Mn)
TABLE 20 Global Cirrhosis Market, by Decompensated Cirrhosis, By Region, 2023-2030 (US$ Mn)
TABLE 21 Global Cirrhosis Market, by Asymptomatic Cirrhosis, By Region, 2017-2022 (US$ Mn)
TABLE 22 Global Cirrhosis Market, by Asymptomatic Cirrhosis, By Region, 2023-2030 (US$ Mn)
TABLE 23 Global Cirrhosis Market, by Symptoms of Decompensated Cirrhosis (Ascites, Variceal Bleeding, Hepatic Encephalopathy, Jaundice), By Region, 2017-2022 (US$ Mn)
TABLE 24 Global Cirrhosis Market, by Symptoms of Decompensated Cirrhosis (Ascites, Variceal Bleeding, Hepatic Encephalopathy, Jaundice), By Region, 2023-2030 (US$ Mn)
TABLE 25 Global Cirrhosis Market, by Child-Pugh Score Class A, By Region, 2017-2022 (US$ Mn)
TABLE 26 Global Cirrhosis Market, by Child-Pugh Score Class A, By Region, 2023-2030 (US$ Mn)
TABLE 27 Global Cirrhosis Market, by Child-Pugh Score Class B, By Region, 2017-2022 (US$ Mn)
TABLE 28 Global Cirrhosis Market, by Child-Pugh Score Class B, By Region, 2023-2030 (US$ Mn)
TABLE 29 Global Cirrhosis Market, by Child-Pugh Score Class C, By Region, 2017-2022 (US$ Mn)
TABLE 30 Global Cirrhosis Market, by Child-Pugh Score Class C, By Region, 2023-2030 (US$ Mn)
TABLE 31 Global Cirrhosis Market, by Hospitals and Clinics, By Region, 2017-2022 (US$ Mn)
TABLE 32 Global Cirrhosis Market, by Hospitals and Clinics, By Region, 2023-2030 (US$ Mn)
TABLE 33 Global Cirrhosis Market, by Specialty Pharmacies, By Region, 2017-2022 (US$ Mn)
TABLE 34 Global Cirrhosis Market, by Specialty Pharmacies, By Region, 2023-2030 (US$ Mn)
TABLE 35 Global Cirrhosis Market, by Retail Pharmacies, By Region, 2017-2022 (US$ Mn)
TABLE 36 Global Cirrhosis Market, by Retail Pharmacies, By Region, 2023-2030 (US$ Mn)
TABLE 37 Global Cirrhosis Market, by Medications (Antivirals, Immunosuppressants), By Region, 2017-2022 (US$ Mn)
TABLE 38 Global Cirrhosis Market, by Medications (Antivirals, Immunosuppressants), By Region, 2023-2030 (US$ Mn)
TABLE 39 Global Cirrhosis Market, by Lifestyle Modifications (Diet, Alcohol Abstinence), By Region, 2017-2022 (US$ Mn)
TABLE 40 Global Cirrhosis Market, by Lifestyle Modifications (Diet, Alcohol Abstinence), By Region, 2023-2030 (US$ Mn)
TABLE 41 Global Cirrhosis Market, by Surgical Interventions (Liver Transplantation), By Region, 2017-2022 (US$ Mn)
TABLE 42 Global Cirrhosis Market, by Surgical Interventions (Liver Transplantation), By Region, 2023-2030 (US$ Mn)
TABLE 43 Global Cirrhosis Market, by Etiology, 2017-2022 (US$ Mn)
TABLE 44 Global Cirrhosis Market, by Etiology, 2023-2030 (US$ Mn)
TABLE 45 Global Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2017-2022 (US$ Mn)
TABLE 46 Global Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2023-2030 (US$ Mn)
TABLE 47 Global Cirrhosis Market, by Clinical Presentation, 2017-2022 (US$ Mn)
TABLE 48 Global Cirrhosis Market, by Clinical Presentation, 2023-2030 (US$ Mn)
TABLE 49 Global Cirrhosis Market, by Disease Severity, By Region, 2017-2022 (US$ Mn)
TABLE 50 Global Cirrhosis Market, by Disease Severity, By Region, 2023-2030 (US$ Mn)
TABLE 51 Global Cirrhosis Market, by Distribution Channels, 2017-2022 (US$ Mn)
TABLE 52 Global Cirrhosis Market, by Distribution Channels, 2023-2030 (US$ Mn)
TABLE 53 Global Cirrhosis Market, by Treatment Approaches, 2017-2022 (US$ Mn)
TABLE 54 Global Cirrhosis Market, by Treatment Approaches, 2023-2030 (US$ Mn)
TABLE 55 Global Cirrhosis Market, by Region, 2017-2022 (US$ Mn)
TABLE 56 Global Cirrhosis Market, by Region, 2023-2030 (US$ Mn)
TABLE 57 North America Cirrhosis Market, by Etiology, 2017-2022 (US$ Mn)
TABLE 58 North America Cirrhosis Market, by Etiology, 2023-2030 (US$ Mn)
TABLE 59 North America Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2017-2022 (US$ Mn)
TABLE 60 North America Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2023-2030 (US$ Mn)
TABLE 61 North America Cirrhosis Market, by Clinical Presentation, 2017-2022 (US$ Mn)
TABLE 62 North America Cirrhosis Market, by Clinical Presentation, 2023-2030 (US$ Mn)
TABLE 63 North America Cirrhosis Market, by Disease Severity, By Region, 2017-2022 (US$ Mn)
TABLE 64 North America Cirrhosis Market, by Disease Severity, By Region, 2023-2030 (US$ Mn)
TABLE 65 North America Cirrhosis Market, by Distribution Channels, 2017-2022 (US$ Mn)
TABLE 66 North America Cirrhosis Market, by Distribution Channels, 2023-2030 (US$ Mn)
TABLE 67 North America Cirrhosis Market, by Treatment Approaches, 2017-2022 (US$ Mn)
TABLE 68 North America Cirrhosis Market, by Treatment Approaches, 2023-2030 (US$ Mn)
TABLE 69 North America Cirrhosis Market, by Country, 2017-2022 (US$ Mn)
TABLE 70 North America Cirrhosis Market, by Country, 2023-2030 (US$ Mn)
TABLE 71 United States Cirrhosis Market, by Etiology, 2017-2022 (US$ Mn)
TABLE 72 United States Cirrhosis Market, by Etiology, 2023-2030 (US$ Mn)
TABLE 73 United States Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2017-2022 (US$ Mn)
TABLE 74 United States Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2023-2030 (US$ Mn)
TABLE 75 United States Cirrhosis Market, by Clinical Presentation, 2017-2022 (US$ Mn)
TABLE 76 United States Cirrhosis Market, by Clinical Presentation, 2023-2030 (US$ Mn)
TABLE 77 United States Cirrhosis Market, by Disease Severity, By Region, 2017-2022 (US$ Mn)
TABLE 78 United States Cirrhosis Market, by Disease Severity, By Region, 2023-2030 (US$ Mn)
TABLE 79 United States Cirrhosis Market, by Distribution Channels, 2017-2022 (US$ Mn)
TABLE 80 United States Cirrhosis Market, by Distribution Channels, 2023-2030 (US$ Mn)
TABLE 81 United States Cirrhosis Market, by Treatment Approaches, 2017-2022 (US$ Mn)
TABLE 82 United States Cirrhosis Market, by Treatment Approaches, 2023-2030 (US$ Mn)
TABLE 83 Canada Cirrhosis Market, by Etiology, 2017-2022 (US$ Mn)
TABLE 84 Canada Cirrhosis Market, by Etiology, 2023-2030 (US$ Mn)
TABLE 85 Canada Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2017-2022 (US$ Mn)
TABLE 86 Canada Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2023-2030 (US$ Mn)
TABLE 87 Canada Cirrhosis Market, by Clinical Presentation, 2017-2022 (US$ Mn)
TABLE 88 Canada Cirrhosis Market, by Clinical Presentation, 2023-2030 (US$ Mn)
TABLE 89 Canada Cirrhosis Market, by Disease Severity, By Region, 2017-2022 (US$ Mn)
TABLE 90 Canada Cirrhosis Market, by Disease Severity, By Region, 2023-2030 (US$ Mn)
TABLE 91 Canada Cirrhosis Market, by Distribution Channels, 2017-2022 (US$ Mn)
TABLE 92 Canada Cirrhosis Market, by Distribution Channels, 2023-2030 (US$ Mn)
TABLE 93 Canada Cirrhosis Market, by Treatment Approaches, 2017-2022 (US$ Mn)
TABLE 94 Canada Cirrhosis Market, by Treatment Approaches, 2023-2030 (US$ Mn)
TABLE 95 Mexico Cirrhosis Market, by Etiology, 2017-2022 (US$ Mn)
TABLE 96 Mexico Cirrhosis Market, by Etiology, 2023-2030 (US$ Mn)
TABLE 97 Mexico Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2017-2022 (US$ Mn)
TABLE 98 Mexico Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2023-2030 (US$ Mn)
TABLE 99 Mexico Cirrhosis Market, by Clinical Presentation, 2017-2022 (US$ Mn)
TABLE 100 Mexico Cirrhosis Market, by Clinical Presentation, 2023-2030 (US$ Mn)
TABLE 101 Mexico Cirrhosis Market, by Disease Severity, By Region, 2017-2022 (US$ Mn)
TABLE 102 Mexico Cirrhosis Market, by Disease Severity, By Region, 2023-2030 (US$ Mn)
TABLE 103 Mexico Cirrhosis Market, by Distribution Channels, 2017-2022 (US$ Mn)
TABLE 104 Mexico Cirrhosis Market, by Distribution Channels, 2023-2030 (US$ Mn)
TABLE 105 Mexico Cirrhosis Market, by Treatment Approaches, 2017-2022 (US$ Mn)
TABLE 106 Mexico Cirrhosis Market, by Treatment Approaches, 2023-2030 (US$ Mn)
TABLE 107 Europe Cirrhosis Market, by Etiology, 2017-2022 (US$ Mn)
TABLE 108 Europe Cirrhosis Market, by Etiology, 2023-2030 (US$ Mn)
TABLE 109 Europe Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2017-2022 (US$ Mn)
TABLE 110 Europe Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2023-2030 (US$ Mn)
TABLE 111 Europe Cirrhosis Market, by Clinical Presentation, 2017-2022 (US$ Mn)
TABLE 112 Europe Cirrhosis Market, by Clinical Presentation, 2023-2030 (US$ Mn)
TABLE 113 Europe Cirrhosis Market, by Disease Severity, By Region, 2017-2022 (US$ Mn)
TABLE 114 Europe Cirrhosis Market, by Disease Severity, By Region, 2023-2030 (US$ Mn)
TABLE 115 Europe Cirrhosis Market, by Distribution Channels, 2017-2022 (US$ Mn)
TABLE 116 Europe Cirrhosis Market, by Distribution Channels, 2023-2030 (US$ Mn)
TABLE 117 Europe Cirrhosis Market, by Treatment Approaches, 2017-2022 (US$ Mn)
TABLE 118 Europe Cirrhosis Market, by Treatment Approaches, 2023-2030 (US$ Mn)
TABLE 119 Europe Cirrhosis Market, by Country, 2017-2022 (US$ Mn)
TABLE 120 Europe Cirrhosis Market, by Country, 2023-2030 (US$ Mn)
TABLE 121 Germany Cirrhosis Market, by Etiology, 2017-2022 (US$ Mn)
TABLE 122 Germany Cirrhosis Market, by Etiology, 2023-2030 (US$ Mn)
TABLE 123 Germany Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2017-2022 (US$ Mn)
TABLE 124 Germany Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2023-2030 (US$ Mn)
TABLE 125 Germany Cirrhosis Market, by Clinical Presentation, 2017-2022 (US$ Mn)
TABLE 126 Germany Cirrhosis Market, by Clinical Presentation, 2023-2030 (US$ Mn)
TABLE 127 Germany Cirrhosis Market, by Disease Severity, By Region, 2017-2022 (US$ Mn)
TABLE 128 Germany Cirrhosis Market, by Disease Severity, By Region, 2023-2030 (US$ Mn)
TABLE 129 Germany Cirrhosis Market, by Distribution Channels, 2017-2022 (US$ Mn)
TABLE 130 Germany Cirrhosis Market, by Distribution Channels, 2023-2030 (US$ Mn)
TABLE 131 Germany Cirrhosis Market, by Treatment Approaches, 2017-2022 (US$ Mn)
TABLE 132 Germany Cirrhosis Market, by Treatment Approaches, 2023-2030 (US$ Mn)
TABLE 133 France Cirrhosis Market, by Etiology, 2017-2022 (US$ Mn)
TABLE 134 France Cirrhosis Market, by Etiology, 2023-2030 (US$ Mn)
TABLE 135 France Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2017-2022 (US$ Mn)
TABLE 136 France Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2023-2030 (US$ Mn)
TABLE 137 France Cirrhosis Market, by Clinical Presentation, 2017-2022 (US$ Mn)
TABLE 138 France Cirrhosis Market, by Clinical Presentation, 2023-2030 (US$ Mn)
TABLE 139 France Cirrhosis Market, by Disease Severity, By Region, 2017-2022 (US$ Mn)
TABLE 140 France Cirrhosis Market, by Disease Severity, By Region, 2023-2030 (US$ Mn)
TABLE 141 France Cirrhosis Market, by Distribution Channels, 2017-2022 (US$ Mn)
TABLE 142 France Cirrhosis Market, by Distribution Channels, 2023-2030 (US$ Mn)
TABLE 143 France Cirrhosis Market, by Treatment Approaches, 2017-2022 (US$ Mn)
TABLE 144 France Cirrhosis Market, by Treatment Approaches, 2023-2030 (US$ Mn)
TABLE 145 United Kingdom Cirrhosis Market, by Etiology, 2017-2022 (US$ Mn)
TABLE 146 United Kingdom Cirrhosis Market, by Etiology, 2023-2030 (US$ Mn)
TABLE 147 United Kingdom Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2017-2022 (US$ Mn)
TABLE 148 United Kingdom Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2023-2030 (US$ Mn)
TABLE 149 United Kingdom Cirrhosis Market, by Clinical Presentation, 2017-2022 (US$ Mn)
TABLE 150 United Kingdom Cirrhosis Market, by Clinical Presentation, 2023-2030 (US$ Mn)
TABLE 151 United Kingdom Cirrhosis Market, by Disease Severity, By Region, 2017-2022 (US$ Mn)
TABLE 152 United Kingdom Cirrhosis Market, by Disease Severity, By Region, 2023-2030 (US$ Mn)
TABLE 153 United Kingdom Cirrhosis Market, by Distribution Channels, 2017-2022 (US$ Mn)
TABLE 154 United Kingdom Cirrhosis Market, by Distribution Channels, 2023-2030 (US$ Mn)
TABLE 155 United Kingdom Cirrhosis Market, by Treatment Approaches, 2017-2022 (US$ Mn)
TABLE 156 United Kingdom Cirrhosis Market, by Treatment Approaches, 2023-2030 (US$ Mn)
TABLE 157 Italy Cirrhosis Market, by Etiology, 2017-2022 (US$ Mn)
TABLE 158 Italy Cirrhosis Market, by Etiology, 2023-2030 (US$ Mn)
TABLE 159 Italy Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2017-2022 (US$ Mn)
TABLE 160 Italy Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2023-2030 (US$ Mn)
TABLE 161 Italy Cirrhosis Market, by Clinical Presentation, 2017-2022 (US$ Mn)
TABLE 162 Italy Cirrhosis Market, by Clinical Presentation, 2023-2030 (US$ Mn)
TABLE 163 Italy Cirrhosis Market, by Disease Severity, By Region, 2017-2022 (US$ Mn)
TABLE 164 Italy Cirrhosis Market, by Disease Severity, By Region, 2023-2030 (US$ Mn)
TABLE 165 Italy Cirrhosis Market, by Distribution Channels, 2017-2022 (US$ Mn)
TABLE 166 Italy Cirrhosis Market, by Distribution Channels, 2023-2030 (US$ Mn)
TABLE 167 Italy Cirrhosis Market, by Treatment Approaches, 2017-2022 (US$ Mn)
TABLE 168 Italy Cirrhosis Market, by Treatment Approaches, 2023-2030 (US$ Mn)
TABLE 169 Spain Cirrhosis Market, by Etiology, 2017-2022 (US$ Mn)
TABLE 170 Spain Cirrhosis Market, by Etiology, 2023-2030 (US$ Mn)
TABLE 171 Spain Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2017-2022 (US$ Mn)
TABLE 172 Spain Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2023-2030 (US$ Mn)
TABLE 173 Spain Cirrhosis Market, by Clinical Presentation, 2017-2022 (US$ Mn)
TABLE 174 Spain Cirrhosis Market, by Clinical Presentation, 2023-2030 (US$ Mn)
TABLE 175 Spain Cirrhosis Market, by Disease Severity, By Region, 2017-2022 (US$ Mn)
TABLE 176 Spain Cirrhosis Market, by Disease Severity, By Region, 2023-2030 (US$ Mn)
TABLE 177 Spain Cirrhosis Market, by Distribution Channels, 2017-2022 (US$ Mn)
TABLE 178 Spain Cirrhosis Market, by Distribution Channels, 2023-2030 (US$ Mn)
TABLE 179 Spain Cirrhosis Market, by Treatment Approaches, 2017-2022 (US$ Mn)
TABLE 180 Spain Cirrhosis Market, by Treatment Approaches, 2023-2030 (US$ Mn)
TABLE 181 Benelux Cirrhosis Market, by Etiology, 2017-2022 (US$ Mn)
TABLE 182 Benelux Cirrhosis Market, by Etiology, 2023-2030 (US$ Mn)
TABLE 183 Benelux Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2017-2022 (US$ Mn)
TABLE 184 Benelux Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2023-2030 (US$ Mn)
TABLE 185 Benelux Cirrhosis Market, by Clinical Presentation, 2017-2022 (US$ Mn)
TABLE 186 Benelux Cirrhosis Market, by Clinical Presentation, 2023-2030 (US$ Mn)
TABLE 187 Benelux Cirrhosis Market, by Disease Severity, By Region, 2017-2022 (US$ Mn)
TABLE 188 Benelux Cirrhosis Market, by Disease Severity, By Region, 2023-2030 (US$ Mn)
TABLE 189 Benelux Cirrhosis Market, by Distribution Channels, 2017-2022 (US$ Mn)
TABLE 190 Benelux Cirrhosis Market, by Distribution Channels, 2023-2030 (US$ Mn)
TABLE 191 Benelux Cirrhosis Market, by Treatment Approaches, 2017-2022 (US$ Mn)
TABLE 192 Benelux Cirrhosis Market, by Treatment Approaches, 2023-2030 (US$ Mn)
TABLE 193 Russia Cirrhosis Market, by Etiology, 2017-2022 (US$ Mn)
TABLE 194 Russia Cirrhosis Market, by Etiology, 2023-2030 (US$ Mn)
TABLE 195 Russia Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2017-2022 (US$ Mn)
TABLE 196 Russia Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2023-2030 (US$ Mn)
TABLE 197 Russia Cirrhosis Market, by Clinical Presentation, 2017-2022 (US$ Mn)
TABLE 198 Russia Cirrhosis Market, by Clinical Presentation, 2023-2030 (US$ Mn)
TABLE 199 Russia Cirrhosis Market, by Disease Severity, By Region, 2017-2022 (US$ Mn)
TABLE 200 Russia Cirrhosis Market, by Disease Severity, By Region, 2023-2030 (US$ Mn)
TABLE 201 Russia Cirrhosis Market, by Distribution Channels, 2017-2022 (US$ Mn)
TABLE 202 Russia Cirrhosis Market, by Distribution Channels, 2023-2030 (US$ Mn)
TABLE 203 Russia Cirrhosis Market, by Treatment Approaches, 2017-2022 (US$ Mn)
TABLE 204 Russia Cirrhosis Market, by Treatment Approaches, 2023-2030 (US$ Mn)
TABLE 205 Rest of Europe Cirrhosis Market, by Etiology, 2017-2022 (US$ Mn)
TABLE 206 Rest of Europe Cirrhosis Market, by Etiology, 2023-2030 (US$ Mn)
TABLE 207 Rest of Europe Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2017-2022 (US$ Mn)
TABLE 208 Rest of Europe Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2023-2030 (US$ Mn)
TABLE 209 Rest of Europe Cirrhosis Market, by Clinical Presentation, 2017-2022 (US$ Mn)
TABLE 210 Rest of Europe Cirrhosis Market, by Clinical Presentation, 2023-2030 (US$ Mn)
TABLE 211 Rest of Europe Cirrhosis Market, by Disease Severity, By Region, 2017-2022 (US$ Mn)
TABLE 212 Rest of Europe Cirrhosis Market, by Disease Severity, By Region, 2023-2030 (US$ Mn)
TABLE 213 Rest of Europe Cirrhosis Market, by Distribution Channels, 2017-2022 (US$ Mn)
TABLE 214 Rest of Europe Cirrhosis Market, by Distribution Channels, 2023-2030 (US$ Mn)
TABLE 215 Rest of Europe Cirrhosis Market, by Treatment Approaches, 2017-2022 (US$ Mn)
TABLE 216 Rest of Europe Cirrhosis Market, by Treatment Approaches, 2023-2030 (US$ Mn)
TABLE 217 Asia Pacific Cirrhosis Market, by Etiology, 2017-2022 (US$ Mn)
TABLE 218 Asia Pacific Cirrhosis Market, by Etiology, 2023-2030 (US$ Mn)
TABLE 219 Asia Pacific Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2017-2022 (US$ Mn)
TABLE 220 Asia Pacific Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2023-2030 (US$ Mn)
TABLE 221 Asia Pacific Cirrhosis Market, by Clinical Presentation, 2017-2022 (US$ Mn)
TABLE 222 Asia Pacific Cirrhosis Market, by Clinical Presentation, 2023-2030 (US$ Mn)
TABLE 223 Asia Pacific Cirrhosis Market, by Disease Severity, By Region, 2017-2022 (US$ Mn)
TABLE 224 Asia Pacific Cirrhosis Market, by Disease Severity, By Region, 2023-2030 (US$ Mn)
TABLE 225 Asia Pacific Cirrhosis Market, by Distribution Channels, 2017-2022 (US$ Mn)
TABLE 226 Asia Pacific Cirrhosis Market, by Distribution Channels, 2023-2030 (US$ Mn)
TABLE 227 Asia Pacific Cirrhosis Market, by Treatment Approaches, 2017-2022 (US$ Mn)
TABLE 228 Asia Pacific Cirrhosis Market, by Treatment Approaches, 2023-2030 (US$ Mn)
TABLE 229 China Cirrhosis Market, by Etiology, 2017-2022 (US$ Mn)
TABLE 230 China Cirrhosis Market, by Etiology, 2023-2030 (US$ Mn)
TABLE 231 China Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2017-2022 (US$ Mn)
TABLE 232 China Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2023-2030 (US$ Mn)
TABLE 233 China Cirrhosis Market, by Clinical Presentation, 2017-2022 (US$ Mn)
TABLE 234 China Cirrhosis Market, by Clinical Presentation, 2023-2030 (US$ Mn)
TABLE 235 China Cirrhosis Market, by Disease Severity, By Region, 2017-2022 (US$ Mn)
TABLE 236 China Cirrhosis Market, by Disease Severity, By Region, 2023-2030 (US$ Mn)
TABLE 237 China Cirrhosis Market, by Distribution Channels, 2017-2022 (US$ Mn)
TABLE 238 China Cirrhosis Market, by Distribution Channels, 2023-2030 (US$ Mn)
TABLE 239 China Cirrhosis Market, by Treatment Approaches, 2017-2022 (US$ Mn)
TABLE 240 China Cirrhosis Market, by Treatment Approaches, 2023-2030 (US$ Mn)
TABLE 241 Japan Cirrhosis Market, by Etiology, 2017-2022 (US$ Mn)
TABLE 242 Japan Cirrhosis Market, by Etiology, 2023-2030 (US$ Mn)
TABLE 243 Japan Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2017-2022 (US$ Mn)
TABLE 244 Japan Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2023-2030 (US$ Mn)
TABLE 245 Japan Cirrhosis Market, by Clinical Presentation, 2017-2022 (US$ Mn)
TABLE 246 Japan Cirrhosis Market, by Clinical Presentation, 2023-2030 (US$ Mn)
TABLE 247 Japan Cirrhosis Market, by Disease Severity, By Region, 2017-2022 (US$ Mn)
TABLE 248 Japan Cirrhosis Market, by Disease Severity, By Region, 2023-2030 (US$ Mn)
TABLE 249 Japan Cirrhosis Market, by Distribution Channels, 2017-2022 (US$ Mn)
TABLE 250 Japan Cirrhosis Market, by Distribution Channels, 2023-2030 (US$ Mn)
TABLE 251 Japan Cirrhosis Market, by Treatment Approaches, 2017-2022 (US$ Mn)
TABLE 252 Japan Cirrhosis Market, by Treatment Approaches, 2023-2030 (US$ Mn)
TABLE 253 India Cirrhosis Market, by Etiology, 2017-2022 (US$ Mn)
TABLE 254 India Cirrhosis Market, by Etiology, 2023-2030 (US$ Mn)
TABLE 255 India Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2017-2022 (US$ Mn)
TABLE 256 India Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2023-2030 (US$ Mn)
TABLE 257 India Cirrhosis Market, by Clinical Presentation, 2017-2022 (US$ Mn)
TABLE 258 India Cirrhosis Market, by Clinical Presentation, 2023-2030 (US$ Mn)
TABLE 259 India Cirrhosis Market, by Disease Severity, By Region, 2017-2022 (US$ Mn)
TABLE 260 India Cirrhosis Market, by Disease Severity, By Region, 2023-2030 (US$ Mn)
TABLE 261 India Cirrhosis Market, by Distribution Channels, 2017-2022 (US$ Mn)
TABLE 262 India Cirrhosis Market, by Distribution Channels, 2023-2030 (US$ Mn)
TABLE 263 India Cirrhosis Market, by Treatment Approaches, 2017-2022 (US$ Mn)
TABLE 264 India Cirrhosis Market, by Treatment Approaches, 2023-2030 (US$ Mn)
TABLE 265 South Korea Cirrhosis Market, by Etiology, 2017-2022 (US$ Mn)
TABLE 266 South Korea Cirrhosis Market, by Etiology, 2023-2030 (US$ Mn)
TABLE 267 South Korea Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2017-2022 (US$ Mn)
TABLE 268 South Korea Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2023-2030 (US$ Mn)
TABLE 269 South Korea Cirrhosis Market, by Clinical Presentation, 2017-2022 (US$ Mn)
TABLE 270 South Korea Cirrhosis Market, by Clinical Presentation, 2023-2030 (US$ Mn)
TABLE 271 South Korea Cirrhosis Market, by Disease Severity, By Region, 2017-2022 (US$ Mn)
TABLE 272 South Korea Cirrhosis Market, by Disease Severity, By Region, 2023-2030 (US$ Mn)
TABLE 273 South Korea Cirrhosis Market, by Distribution Channels, 2017-2022 (US$ Mn)
TABLE 274 South Korea Cirrhosis Market, by Distribution Channels, 2023-2030 (US$ Mn)
TABLE 275 South Korea Cirrhosis Market, by Treatment Approaches, 2017-2022 (US$ Mn)
TABLE 276 South Korea Cirrhosis Market, by Treatment Approaches, 2023-2030 (US$ Mn)
TABLE 277 South-East Asia Cirrhosis Market, by Etiology, 2017-2022 (US$ Mn)
TABLE 278 South-East Asia Cirrhosis Market, by Etiology, 2023-2030 (US$ Mn)
TABLE 279 South-East Asia Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2017-2022 (US$ Mn)
TABLE 280 South-East Asia Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2023-2030 (US$ Mn)
TABLE 281 South-East Asia Cirrhosis Market, by Clinical Presentation, 2017-2022 (US$ Mn)
TABLE 282 South-East Asia Cirrhosis Market, by Clinical Presentation, 2023-2030 (US$ Mn)
TABLE 283 South-East Asia Cirrhosis Market, by Disease Severity, By Region, 2017-2022 (US$ Mn)
TABLE 284 South-East Asia Cirrhosis Market, by Disease Severity, By Region, 2023-2030 (US$ Mn)
TABLE 285 South-East Asia Cirrhosis Market, by Distribution Channels, 2017-2022 (US$ Mn)
TABLE 286 South-East Asia Cirrhosis Market, by Distribution Channels, 2023-2030 (US$ Mn)
TABLE 287 South-East Asia Cirrhosis Market, by Treatment Approaches, 2017-2022 (US$ Mn)
TABLE 288 South-East Asia Cirrhosis Market, by Treatment Approaches, 2023-2030 (US$ Mn)
TABLE 289 Rest of Asia Pacific Cirrhosis Market, by Etiology, 2017-2022 (US$ Mn)
TABLE 290 Rest of Asia Pacific Cirrhosis Market, by Etiology, 2023-2030 (US$ Mn)
TABLE 291 Rest of Asia Pacific Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2017-2022 (US$ Mn)
TABLE 292 Rest of Asia Pacific Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2023-2030 (US$ Mn)
TABLE 293 Rest of Asia Pacific Cirrhosis Market, by Clinical Presentation, 2017-2022 (US$ Mn)
TABLE 294 Rest of Asia Pacific Cirrhosis Market, by Clinical Presentation, 2023-2030 (US$ Mn)
TABLE 295 Rest of Asia Pacific Cirrhosis Market, by Disease Severity, By Region, 2017-2022 (US$ Mn)
TABLE 296 Rest of Asia Pacific Cirrhosis Market, by Disease Severity, By Region, 2023-2030 (US$ Mn)
TABLE 297 Rest of Asia Pacific Cirrhosis Market, by Distribution Channels, 2017-2022 (US$ Mn)
TABLE 298 Rest of Asia Pacific Cirrhosis Market, by Distribution Channels, 2023-2030 (US$ Mn)
TABLE 299 Rest of Asia Pacific Cirrhosis Market, by Treatment Approaches, 2017-2022 (US$ Mn)
TABLE 300 Rest of Asia Pacific Cirrhosis Market, by Treatment Approaches, 2023-2030 (US$ Mn)
TABLE 301 Latin America Cirrhosis Market, by Etiology, 2017-2022 (US$ Mn)
TABLE 302 Latin America Cirrhosis Market, by Etiology, 2023-2030 (US$ Mn)
TABLE 303 Latin America Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2017-2022 (US$ Mn)
TABLE 304 Latin America Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2023-2030 (US$ Mn)
TABLE 305 Latin America Cirrhosis Market, by Clinical Presentation, 2017-2022 (US$ Mn)
TABLE 306 Latin America Cirrhosis Market, by Clinical Presentation, 2023-2030 (US$ Mn)
TABLE 307 Latin America Cirrhosis Market, by Disease Severity, By Region, 2017-2022 (US$ Mn)
TABLE 308 Latin America Cirrhosis Market, by Disease Severity, By Region, 2023-2030 (US$ Mn)
TABLE 309 Latin America Cirrhosis Market, by Distribution Channels, 2017-2022 (US$ Mn)
TABLE 310 Latin America Cirrhosis Market, by Distribution Channels, 2023-2030 (US$ Mn)
TABLE 311 Latin America Cirrhosis Market, by Treatment Approaches, 2017-2022 (US$ Mn)
TABLE 312 Latin America Cirrhosis Market, by Treatment Approaches, 2023-2030 (US$ Mn)
TABLE 313 Brazil Cirrhosis Market, by Etiology, 2017-2022 (US$ Mn)
TABLE 314 Brazil Cirrhosis Market, by Etiology, 2023-2030 (US$ Mn)
TABLE 315 Brazil Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2017-2022 (US$ Mn)
TABLE 316 Brazil Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2023-2030 (US$ Mn)
TABLE 317 Brazil Cirrhosis Market, by Clinical Presentation, 2017-2022 (US$ Mn)
TABLE 318 Brazil Cirrhosis Market, by Clinical Presentation, 2023-2030 (US$ Mn)
TABLE 319 Brazil Cirrhosis Market, by Disease Severity, By Region, 2017-2022 (US$ Mn)
TABLE 320 Brazil Cirrhosis Market, by Disease Severity, By Region, 2023-2030 (US$ Mn)
TABLE 321 Brazil Cirrhosis Market, by Distribution Channels, 2017-2022 (US$ Mn)
TABLE 322 Brazil Cirrhosis Market, by Distribution Channels, 2023-2030 (US$ Mn)
TABLE 323 Brazil Cirrhosis Market, by Treatment Approaches, 2017-2022 (US$ Mn)
TABLE 324 Brazil Cirrhosis Market, by Treatment Approaches, 2023-2030 (US$ Mn)
TABLE 325 Argentina Cirrhosis Market, by Etiology, 2017-2022 (US$ Mn)
TABLE 326 Argentina Cirrhosis Market, by Etiology, 2023-2030 (US$ Mn)
TABLE 327 Argentina Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2017-2022 (US$ Mn)
TABLE 328 Argentina Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2023-2030 (US$ Mn)
TABLE 329 Argentina Cirrhosis Market, by Clinical Presentation, 2017-2022 (US$ Mn)
TABLE 330 Argentina Cirrhosis Market, by Clinical Presentation, 2023-2030 (US$ Mn)
TABLE 331 Argentina Cirrhosis Market, by Disease Severity, By Region, 2017-2022 (US$ Mn)
TABLE 332 Argentina Cirrhosis Market, by Disease Severity, By Region, 2023-2030 (US$ Mn)
TABLE 333 Argentina Cirrhosis Market, by Distribution Channels, 2017-2022 (US$ Mn)
TABLE 334 Argentina Cirrhosis Market, by Distribution Channels, 2023-2030 (US$ Mn)
TABLE 335 Argentina Cirrhosis Market, by Treatment Approaches, 2017-2022 (US$ Mn)
TABLE 336 Argentina Cirrhosis Market, by Treatment Approaches, 2023-2030 (US$ Mn)
TABLE 337 Rest of Latin America Cirrhosis Market, by Etiology, 2017-2022 (US$ Mn)
TABLE 338 Rest of Latin America Cirrhosis Market, by Etiology, 2023-2030 (US$ Mn)
TABLE 339 Rest of Latin America Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2017-2022 (US$ Mn)
TABLE 340 Rest of Latin America Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2023-2030 (US$ Mn)
TABLE 341 Rest of Latin America Cirrhosis Market, by Clinical Presentation, 2017-2022 (US$ Mn)
TABLE 342 Rest of Latin America Cirrhosis Market, by Clinical Presentation, 2023-2030 (US$ Mn)
TABLE 343 Rest of Latin America Cirrhosis Market, by Disease Severity, By Region, 2017-2022 (US$ Mn)
TABLE 344 Rest of Latin America Cirrhosis Market, by Disease Severity, By Region, 2023-2030 (US$ Mn)
TABLE 345 Rest of Latin America Cirrhosis Market, by Distribution Channels, 2017-2022 (US$ Mn)
TABLE 346 Rest of Latin America Cirrhosis Market, by Distribution Channels, 2023-2030 (US$ Mn)
TABLE 347 Rest of Latin America Cirrhosis Market, by Treatment Approaches, 2017-2022 (US$ Mn)
TABLE 348 Rest of Latin America Cirrhosis Market, by Treatment Approaches, 2023-2030 (US$ Mn)
TABLE 349 Middle East Cirrhosis Market, by Etiology, 2017-2022 (US$ Mn)
TABLE 350 Middle East Cirrhosis Market, by Etiology, 2023-2030 (US$ Mn)
TABLE 351 Middle East Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2017-2022 (US$ Mn)
TABLE 352 Middle East Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2023-2030 (US$ Mn)
TABLE 353 Middle East Cirrhosis Market, by Clinical Presentation, 2017-2022 (US$ Mn)
TABLE 354 Middle East Cirrhosis Market, by Clinical Presentation, 2023-2030 (US$ Mn)
TABLE 355 Middle East Cirrhosis Market, by Disease Severity, By Region, 2017-2022 (US$ Mn)
TABLE 356 Middle East Cirrhosis Market, by Disease Severity, By Region, 2023-2030 (US$ Mn)
TABLE 357 Middle East Cirrhosis Market, by Distribution Channels, 2017-2022 (US$ Mn)
TABLE 358 Middle East Cirrhosis Market, by Distribution Channels, 2023-2030 (US$ Mn)
TABLE 359 Middle East Cirrhosis Market, by Treatment Approaches, 2017-2022 (US$ Mn)
TABLE 360 Middle East Cirrhosis Market, by Treatment Approaches, 2023-2030 (US$ Mn)
TABLE 361 UAE Cirrhosis Market, by Etiology, 2017-2022 (US$ Mn)
TABLE 362 UAE Cirrhosis Market, by Etiology, 2023-2030 (US$ Mn)
TABLE 363 UAE Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2017-2022 (US$ Mn)
TABLE 364 UAE Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2023-2030 (US$ Mn)
TABLE 365 UAE Cirrhosis Market, by Clinical Presentation, 2017-2022 (US$ Mn)
TABLE 366 UAE Cirrhosis Market, by Clinical Presentation, 2023-2030 (US$ Mn)
TABLE 367 UAE Cirrhosis Market, by Disease Severity, By Region, 2017-2022 (US$ Mn)
TABLE 368 UAE Cirrhosis Market, by Disease Severity, By Region, 2023-2030 (US$ Mn)
TABLE 369 UAE Cirrhosis Market, by Distribution Channels, 2017-2022 (US$ Mn)
TABLE 370 UAE Cirrhosis Market, by Distribution Channels, 2023-2030 (US$ Mn)
TABLE 371 UAE Cirrhosis Market, by Treatment Approaches, 2017-2022 (US$ Mn)
TABLE 372 UAE Cirrhosis Market, by Treatment Approaches, 2023-2030 (US$ Mn)
TABLE 373 Saudi Arabia Cirrhosis Market, by Etiology, 2017-2022 (US$ Mn)
TABLE 374 Saudi Arabia Cirrhosis Market, by Etiology, 2023-2030 (US$ Mn)
TABLE 375 Saudi Arabia Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2017-2022 (US$ Mn)
TABLE 376 Saudi Arabia Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2023-2030 (US$ Mn)
TABLE 377 Saudi Arabia Cirrhosis Market, by Clinical Presentation, 2017-2022 (US$ Mn)
TABLE 378 Saudi Arabia Cirrhosis Market, by Clinical Presentation, 2023-2030 (US$ Mn)
TABLE 379 Saudi Arabia Cirrhosis Market, by Disease Severity, By Region, 2017-2022 (US$ Mn)
TABLE 380 Saudi Arabia Cirrhosis Market, by Disease Severity, By Region, 2023-2030 (US$ Mn)
TABLE 381 Saudi Arabia Cirrhosis Market, by Distribution Channels, 2017-2022 (US$ Mn)
TABLE 382 Saudi Arabia Cirrhosis Market, by Distribution Channels, 2023-2030 (US$ Mn)
TABLE 383 Saudi Arabia Cirrhosis Market, by Treatment Approaches, 2017-2022 (US$ Mn)
TABLE 384 Saudi Arabia Cirrhosis Market, by Treatment Approaches, 2023-2030 (US$ Mn)
TABLE 385 Rest of Middle East Cirrhosis Market, by Etiology, 2017-2022 (US$ Mn)
TABLE 386 Rest of Middle East Cirrhosis Market, by Etiology, 2023-2030 (US$ Mn)
TABLE 387 Rest of Middle East Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2017-2022 (US$ Mn)
TABLE 388 Rest of Middle East Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2023-2030 (US$ Mn)
TABLE 389 Rest of Middle East Cirrhosis Market, by Clinical Presentation, 2017-2022 (US$ Mn)
TABLE 390 Rest of Middle East Cirrhosis Market, by Clinical Presentation, 2023-2030 (US$ Mn)
TABLE 391 Rest of Middle East Cirrhosis Market, by Disease Severity, By Region, 2017-2022 (US$ Mn)
TABLE 392 Rest of Middle East Cirrhosis Market, by Disease Severity, By Region, 2023-2030 (US$ Mn)
TABLE 393 Rest of Middle East Cirrhosis Market, by Distribution Channels, 2017-2022 (US$ Mn)
TABLE 394 Rest of Middle East Cirrhosis Market, by Distribution Channels, 2023-2030 (US$ Mn)
TABLE 395 Rest of Middle East Cirrhosis Market, by Treatment Approaches, 2017-2022 (US$ Mn)
TABLE 396 Rest of Middle East Cirrhosis Market, by Treatment Approaches, 2023-2030 (US$ Mn)
TABLE 397 Africa Cirrhosis Market, by Etiology, 2017-2022 (US$ Mn)
TABLE 398 Africa Cirrhosis Market, by Etiology, 2023-2030 (US$ Mn)
TABLE 399 Africa Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2017-2022 (US$ Mn)
TABLE 400 Africa Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2023-2030 (US$ Mn)
TABLE 401 Africa Cirrhosis Market, by Clinical Presentation, 2017-2022 (US$ Mn)
TABLE 402 Africa Cirrhosis Market, by Clinical Presentation, 2023-2030 (US$ Mn)
TABLE 403 Africa Cirrhosis Market, by Disease Severity, By Region, 2017-2022 (US$ Mn)
TABLE 404 Africa Cirrhosis Market, by Disease Severity, By Region, 2023-2030 (US$ Mn)
TABLE 405 Africa Cirrhosis Market, by Distribution Channels, 2017-2022 (US$ Mn)
TABLE 406 Africa Cirrhosis Market, by Distribution Channels, 2023-2030 (US$ Mn)
TABLE 407 Africa Cirrhosis Market, by Treatment Approaches, 2017-2022 (US$ Mn)
TABLE 408 Africa Cirrhosis Market, by Treatment Approaches, 2023-2030 (US$ Mn)
TABLE 409 South Africa Cirrhosis Market, by Etiology, 2017-2022 (US$ Mn)
TABLE 410 South Africa Cirrhosis Market, by Etiology, 2023-2030 (US$ Mn)
TABLE 411 South Africa Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2017-2022 (US$ Mn)
TABLE 412 South Africa Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2023-2030 (US$ Mn)
TABLE 413 South Africa Cirrhosis Market, by Clinical Presentation, 2017-2022 (US$ Mn)
TABLE 414 South Africa Cirrhosis Market, by Clinical Presentation, 2023-2030 (US$ Mn)
TABLE 415 South Africa Cirrhosis Market, by Disease Severity, By Region, 2017-2022 (US$ Mn)
TABLE 416 South Africa Cirrhosis Market, by Disease Severity, By Region, 2023-2030 (US$ Mn)
TABLE 417 South Africa Cirrhosis Market, by Distribution Channels, 2017-2022 (US$ Mn)
TABLE 418 South Africa Cirrhosis Market, by Distribution Channels, 2023-2030 (US$ Mn)
TABLE 419 South Africa Cirrhosis Market, by Treatment Approaches, 2017-2022 (US$ Mn)
TABLE 420 South Africa Cirrhosis Market, by Treatment Approaches, 2023-2030 (US$ Mn)
TABLE 421 Egypt Cirrhosis Market, by Etiology, 2017-2022 (US$ Mn)
TABLE 422 Egypt Cirrhosis Market, by Etiology, 2023-2030 (US$ Mn)
TABLE 423 Egypt Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2017-2022 (US$ Mn)
TABLE 424 Egypt Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2023-2030 (US$ Mn)
TABLE 425 Egypt Cirrhosis Market, by Clinical Presentation, 2017-2022 (US$ Mn)
TABLE 426 Egypt Cirrhosis Market, by Clinical Presentation, 2023-2030 (US$ Mn)
TABLE 427 Egypt Cirrhosis Market, by Disease Severity, By Region, 2017-2022 (US$ Mn)
TABLE 428 Egypt Cirrhosis Market, by Disease Severity, By Region, 2023-2030 (US$ Mn)
TABLE 429 Egypt Cirrhosis Market, by Distribution Channels, 2017-2022 (US$ Mn)
TABLE 430 Egypt Cirrhosis Market, by Distribution Channels, 2023-2030 (US$ Mn)
TABLE 431 Egypt Cirrhosis Market, by Treatment Approaches, 2017-2022 (US$ Mn)
TABLE 432 Egypt Cirrhosis Market, by Treatment Approaches, 2023-2030 (US$ Mn)
TABLE 433 Rest of Africa Cirrhosis Market, by Etiology, 2017-2022 (US$ Mn)
TABLE 434 Rest of Africa Cirrhosis Market, by Etiology, 2023-2030 (US$ Mn)
TABLE 435 Rest of Africa Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2017-2022 (US$ Mn)
TABLE 436 Rest of Africa Cirrhosis Market, by Compensated vs. Decompensated Cirrhosis, 2023-2030 (US$ Mn)
TABLE 437 Rest of Africa Cirrhosis Market, by Clinical Presentation, 2017-2022 (US$ Mn)
TABLE 438 Rest of Africa Cirrhosis Market, by Clinical Presentation, 2023-2030 (US$ Mn)
TABLE 439 Rest of Africa Cirrhosis Market, by Disease Severity, By Region, 2017-2022 (US$ Mn)
TABLE 440 Rest of Africa Cirrhosis Market, by Disease Severity, By Region, 2023-2030 (US$ Mn)
TABLE 441 Rest of Africa Cirrhosis Market, by Distribution Channels, 2017-2022 (US$ Mn)
TABLE 442 Rest of Africa Cirrhosis Market, by Distribution Channels, 2023-2030 (US$ Mn)
TABLE 443 Rest of Africa Cirrhosis Market, by Treatment Approaches, 2017-2022 (US$ Mn)
TABLE 444 Rest of Africa Cirrhosis Market, by Treatment Approaches, 2023-2030 (US$ Mn)